Algo version: 0.98b
CellSource Co., Ltd. is listed at the JPX Exchange
CellSource Co., Ltd. [4880.T]
JPX Sector: Healthcare Industry:Biotechnology

Is CellSource Co., Ltd. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, CellSource Co., Ltd. pays dividends. Last time was Wednesday 1st of January 2025 where the investors holding the stock on Wednesday 30th of October 2024 were paid JPY5 per share. Over the last 2 times between 2023 and 2024, CellSource Co., Ltd. has paid JPY20 with an average of JPY10 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for CellSource Co., Ltd. 10 years ago, but if you had invested on Tuesday 29th of October 2019 when the price was JPY780.00, you would have made a profit of JPY636.00 per share or 81.54%

Yes, the average daily trading liquidity for CellSource Co., Ltd. is JPY141 806 thousand. You should therefore be able to get in and out of your positions relatively fast.

CellSource Co., Ltd. has no real debt, which is good in periods of high inflation. CellSource Co., Ltd. has a good net profit margin of 17.80% and should have high tolerances against inflation.

We have calculated the inflation risk for CellSource Co., Ltd. to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.